propranolol has been researched along with Bladder Cancer in 5 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol is a well-documented medical therapy for cutaneous lesions, but surgical treatment dominates the literature on bladder haemangiomas." | 5.51 | Propranolol as an effective therapy for infantile haemangioma of the urinary bladder. ( Anwar, T; Malm-Buatsi, E, 2019) |
| "Propranolol treatment elevated the activity of caspase-3 and expression of bax, Wee1, GADD153 and apoptosis-inducing factor, but decreased bcl-2 which is an antiapoptotic protein." | 1.72 | Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways. ( Özler, S; Pazarci, P, 2022) |
| "Propranolol is a well-documented medical therapy for cutaneous lesions, but surgical treatment dominates the literature on bladder haemangiomas." | 1.51 | Propranolol as an effective therapy for infantile haemangioma of the urinary bladder. ( Anwar, T; Malm-Buatsi, E, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Özler, S | 1 |
| Pazarci, P | 1 |
| Anwar, T | 1 |
| Malm-Buatsi, E | 1 |
| Brightling, CE | 1 |
| Baker, AJ | 1 |
| Fuller, RW | 1 |
| Raper, AJ | 1 |
| Jessee, EF | 1 |
| Texter, JH | 1 |
| Giffler, RF | 1 |
| Hietala, TS | 1 |
| Harrison, TS | 1 |
| Freier, DT | 1 |
| Cohen, EL | 1 |
5 other studies available for propranolol and Bladder Cancer
| Article | Year |
|---|---|
Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways.
Topics: Adrenergic beta-Antagonists; Apoptosis; Cell Line, Tumor; Female; Humans; Male; Mitogen-Activated Pr | 2022 |
Propranolol as an effective therapy for infantile haemangioma of the urinary bladder.
Topics: Female; Hemangioma; Humans; Infant, Newborn; Propranolol; Treatment Outcome; Urinary Bladder Neoplas | 2019 |
Isoprenaline inhibits thromboxane B2 release from U937 cells.
Topics: Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Flurbiprofen; Humans; Isoproteren | 1993 |
Pheochromocytoma of the urinary bladder: a broad clinical spectrum.
Topics: Adult; Catecholamines; Female; Humans; Hypertension; Phenoxybenzamine; Phentolamine; Pheochromocytom | 1977 |
Proceedings: Recurrent pheochromocytoma.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Adult; Child; Epinephrine; Female; Hormone | 1974 |